GLIMEPIRIDE vs GLOFITAMAB-GXBM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLIMEPIRIDE vs GLOFITAMAB-GXBM: Safety Overview
| Metric | GLIMEPIRIDE | GLOFITAMAB-GXBM |
|---|---|---|
| Total FAERS Reports | 5,572 | 498 |
| Deaths Reported | 552 | 175 |
| Death Rate | 9.9% | 35.1% |
| Hospitalizations | 2,550 | 113 |
| Average Patient Age | 66.6 yrs | 60.0 yrs |
| % Female Patients | 46.4% | 36.2% |
| FDA Approval Date | Apr 17, 2013 | N/A |
| Manufacturer | A-S Medication Solutions | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | Prescription |